Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 1997

View Archived Issues

MGI Pharma: Q3 1997 highlights

Bone Care: Q3 1997 highlights

Lilly: Q3 1997 highlights

BioCryst: Q3 1997 highlights

Atlantic's 2-5A improves efficacy of antisense compounds

First report of efficacy for rotavirus vaccine in a developing country

ADCON-L up for advisory committee review

Dusa reports positive phase III results for Levulan PDT

Hyal invests in breast cancer detection technology

Major advance in thalassemia research reported

Alza acquires rights to Ditropan

TBC-1269 enters phase II for treatment and prevention of asthma

Nicotrol launched in Austria as OTC

VEGF inhibitors described by Zeneca

Janssen discloses agents that promote gastrointestinal motility

New antidiabetic agents from Boehringer Mannheim

Abbott develops inhibitors of LT biosynthesis

Improved DNA topoisomerase poisons discovered at Rutgers

Anti-H. pylori cephems claimed by Fujisawa

New antimitotic agents presented by Kyowa Hakko

New DC-107 derivative presented at cancer meeting

Cellular target of new antitumor agent from Nippon Shinyaku identified

Nikken presents new modulator of multidrug resistance

NCA-0465: new antitumor indoloquinoxaline derivative

Preclinical studies on TZT-1027, an antitumor dolastatin 10 derivative

Taiho reports preclinical studies on TAS-103

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Development of antipsychotic agent discontinued

Synthetic retinoid with antiangiogenic/apoptosis-inducing effects from Taiho

MS-209 reverses MDR mediated by MRP and P-glycoprotein

Jenner Technologies changes name

Photofrin now available in France and Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...